Navigation Links
ViroPharma Incorporated Reports Third Quarter 2008 Financial Results
Date:10/29/2008

our ability to file an initial NDA, MAA and NDS for maribavir in 2009, the timing and content of final IDSA/SHEA CDI treatment guidelines, the effectiveness of our Vancocin sales efforts, our estimates of future tax rates, or our ability to execute a successful launch of Cinryze later this year. ViroPharma's 2008 revenue guidance is based upon the Company's plans to remain vigorous in its opposition to any bioequivalence approach considered for use in approving generic formulations of Vancocin that does not require rigorous scientific methods to demonstrate safety and efficacy consistent with good medicine and science. There can be no assurance that the FDA will agree with the positions stated in ViroPharma's Vancocin related submissions or that ViroPharma's efforts to oppose the OGD's March 2006 recommendation to determine bioequivalence to Vancocin through in vitro dissolution testing will be successful. We cannot predict the timeframe in which the FDA will make a decision regarding either ViroPharma's citizen petition for Vancocin or the approval of generic versions of Vancocin. If we are unable to change the recommendation set forth by the OGD in March 2006, the threat of generic competition will be high. The entry of competing generic products will significantly affect our sales of Vancocin and our financial performance.

The company's actual results may vary depending on a variety of factors, including:

-- the development of competitive generic versions of oral Vancocin;

-- our ability to successfully commercialize Cinryze;

-- the availability of third party payer reimbursement for Cinryze

patients;

-- approval of products which are currently marketed for other indications

by other companies or new pharmaceuticals and technological advances to

treat the conditions addressed by Vancocin or Cinryze;

-- fluctuations in wholesaler order patterns and inventory levels;

-- manufacturing, s
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. ViroPharma to Release 2008 Second Quarter Financial Results on July 30, 2008
2. ViroPharma Incorporated Reports First Quarter 2008 Financial Results
3. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
4. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
5. ViroPharma Provides Update on Vancocin(R)
6. ViroPharma Augments Senior Management
7. ViroPharma to Present at the 26th Annual JP Morgan Healthcare Conference
8. ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
9. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
10. ViroPharma to Present at the UBS Global Life Sciences Conference
11. ViroPharma to Present at the Maxim Group First Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Grove Village, IL (PRWEB) August 29, 2014 ... Kathleen Baty, “The Safety Chick” who profiled a ... ETY•Kids® Safe-Listening Earphones from Etymotic Research. This year, ... supply list, and Etymotic, an innovator of hearing ... young ears. Their ETY•Kids Safe-Listening Earphones, offered in ...
(Date:8/29/2014)... The microbiology testing sector is one of the ... is also the hugest challenge facing suppliers during these ... of AIDS – still the world’s key health threat ... opportunistic infections (OIs); bioterrorism threat; advancements in technologies for ... Although for certain infections the etiology remains a mystery, ...
(Date:8/29/2014)... Virginia Beach, VA (PRWEB) August 29, 2014 ... of the top ten tools for online teaching, as ... Award for Best Course or Learning Management System, announced ... Center of America, Metis Leadership Group, Interactive Advertising Bureau ... to the user community. , “We are delighted to ...
(Date:8/29/2014)... August 30, 2014 Top10inaction, a professional ... conference providers in the online service industry for the ... global leaders Webex, GotoMeeting and Infinite. , With over ... have to determine which provider is ideally a good ... businesses search for compelling consumer goods and services agencies ...
(Date:8/29/2014)... 29, 2014 After having a double ... had to have breast reconstruction. She found that the ... she decided that there needed to be a solution. ... a woman or man who needs or wants breast ... promotes confidence and peace of mind. Producible in design ...
Breaking Medicine News(10 mins):Health News:The Today Show Features ETY•Kids® Safe-Listening Earphones by Etymotic 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 3Health News:Edvance360 Continues to Experience Growth in Corporate, K-12, Health, and Non-Profit Sectors 2Health News:Top10InAction Reveals Best Web Conference Providers 2
... are conducted periodically to check fitness in students. Jack ... year's results of the annual assessment of fifth, seventh ... the fifth, seventh and ninth graders and studies student ... the test this year. Only one-third could meet the ...
... dangerous information available on the internet is causing eating ... // ,The NHS Quality Improvement Scotland (NHS ... have been increasing the dangers faced by thousands of ... ,The first ever guidelines have been issued ...
... attacks are less likely to have properly managed the ... quality of life, a new study finds. ... Health Cooperative in Seattle, said her group's previous work ... more diabetes symptom, and lower functioning. 'But because panic ...
... ON HEART IN CHILDREN // ,For children, even mild ... enlargement of the heart, according to results of a study ... Children's Hospital at Montefiore in Bronx, New York. ... higher the blood pressure the worse the strain on the ...
... UK opine that new measures have to be considered to ... comprehensive immunization from the health officials in India, almost one-third ... ,According to the experts in UK, the ... to improper sanitation and congestion of living space. These obstacles ...
... that he proposed to introduce a bill that would ... bill is better known as "Texas Smoke-Free Workplace Law." ... be banned under legislation. ,Ellis made his announcement on the ... Great American Smokeout. ,"Even though cities all over ...
Cached Medicine News:Health News:Internet Health Advice Causing More Harm than Good 2Health News:Panic Attacks Can Increase Complications in Diabetes Patients 2Health News:Children and Chronic Kidney Disease 2Health News:Children and Chronic Kidney Disease 3Health News:Polio can be eradicated in India: Health Experts 2
(Date:8/29/2014)... , August 29, 2014 Pixcelldata, ... collaboration software has announced a major new deal with ... by renowned pathology expert, Dr. Marius Nap . ... the 26th European Congress of Pathology which is taking ... ExCeL Arena, London where Pixcelldata ...
(Date:8/28/2014)... WILMINGTON, Del. , Aug. 28, 2014  Rigrodsky & Long, ... shares of Lannett Company, Inc. (NYSE: LCI )? , ... between September 10, 2013 and July 16, 2014, inclusive? , ... Inc.? , Do you want to discuss your rights? ... former Special Assistant United States Attorney, Timothy J. MacFall , ...
(Date:8/28/2014)... 28, 2014  Decision Resources Group finds that ... strongly through 2022 at a compound annual growth ... largely supported by strong population growth and a ... imaging procedures. The Indian government,s greater investment in ... purchase or upgrade diagnostic imaging equipment. ...
Breaking Medicine Technology:Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 2Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 3
... NEW YORK, Dec. 2 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... and Drug Administration (FDA) has granted Fast Track designation ... anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, ... , The Fast Track program of the FDA is ...
... BIRMINGHAM, Ala., Dec. 2 Adults are more likely to ... over, the odds of losing vision are one in three, whereas the ... odds of a woman developing breast cancer are one in nine. ... risk of injuries, depression and inability to complete daily tasks. , Vision ...
Cached Medicine Technology:Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2
... an affordable solution for low volume workloads, ... menu includes a variety of clotting assays, ... ACL 1000 also offers bar code capability ... Plus, it's backed by superior technology that ...
... workstation offers a broad menu, ... the mid-size lab that processes ... day. Like all SYNCHRON CX-S ... to use, easy to maintain ...
... way to improve your laboratory's testing process, ... menu profiler eliminates time-consuming manual processes and ... Plus, the CX9 PRO performs a comprehensive ... DATs, proteins and serologies -- and provides ...
When it comes to providing speed, accuracy and menu flexibility, the SYNCHRON CX5 PRO has it all. The state-of-the-art CX5 PRO starts with the wide SYNCHRON chemistry menu to create the ideal full-se...
Medicine Products: